Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Management of Hypoglycemia in Renal Donors

Recognition and Initial Assessment

  • The American Diabetes Association recommends checking blood glucose levels in all renal donors with symptoms suggestive of hypoglycemia, particularly those with altered mental status, agitation, or diaphoresis 1, 2
  • Hypoglycemia is defined as blood glucose <70 mg/dL, with severe hypoglycemia requiring third-party assistance 1
  • Signs and symptoms can be confused with other conditions, making prompt blood glucose measurement essential 1

Immediate Treatment Protocol

  • For mild to moderate hypoglycemia, the American Diabetes Association recommends administering 15-20g of oral glucose, followed by blood glucose monitoring every 15 minutes until levels return to normal (>70 mg/dL) 1, 3
  • Treatment should be repeated until blood glucose returns to normal (>70 mg/dL) 1

Prevention Strategies

  • The American Diabetes Association recommends identifying renal donors at higher risk for hypoglycemia and ensuring proper timing of meals relative to medication administration 1, 4
  • Maintaining access to glucose-containing foods or glucose tablets is also recommended 1
  • Avoid targeting overly tight glucose control; aim to keep blood glucose >70 mg/dL but do not target upper limits <150 mg/dL 2, 5
  • Providing a glucose calorie source to prevent hypoglycemia in at-risk patients is also recommended 5

Special Considerations for Renal Donors

  • Consider continuous glucose monitoring for high-risk donors to detect asymptomatic hypoglycemia 6

Medication Adjustments

  • The Endocrine Society recommends reviewing and adjusting antidiabetic medications as needed based on renal function 7
  • For insulin-dependent patients, consider reducing insulin doses by 25-50% based on the degree of renal impairment 7
  • Avoid medications that may increase hypoglycemia risk or interact with antidiabetic drugs 8
  • Ensure appropriate medication access and administration schedule 1